Trihydroxyflavones with antioxidant and anti-inflammatory efficacy

BioFactors

Volumn 38, Issue 5, 2012, Pages 378-386

  Gomes, Ana ^a   Couto, Diana ^a   Alves, Andreia ^a   Dias, Irene ^a   Freitas, Marisa ^a   Porto, Graça ^b   Duarte, José Alberto ^a   Fernandes, Eduarda ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

5 lipoxygenase; Cyclooxygenase 1; Cyclooxygenase 2; Hydroxyflavones; Oxidative burst; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

3,3',4' TRIHYDROXYFLAVONE; 3,7,3' TRIHYDROXYFLAVONE; 3,7,4 TRIHYDROXYFLAVONE; ANTIINFLAMMATORY AGENT; ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FREE RADICAL; GALANGIN; LEUKOTRIENE B4; PROSTAGLANDIN SYNTHASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ACTIVATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IC 50; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ARACHIDONATE 5-LIPOXYGENASE; CELL-FREE SYSTEM; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; FLAVONOIDS; HUMANS; LEUKOTRIENE B4; LIPOXYGENASE INHIBITORS; NEUTROPHIL ACTIVATION; NEUTROPHILS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84867684223     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1033     Document Type: Article

References (52)

1. Gomes, A., Fernandes, E., Lima, J. L. F. C., Mira, L., and Corvo, M. L. (2008) Molecular mechanisms of anti-inflammatory activity mediated by flavonoids. Curr. Med. Chem. 15, 1586-1605.
2. Vapaatalo, H. (1986) Free radicals and anti-inflammatory drugs. Med. Biol. 64, 1-7.
3. Halliwell, B., Hoult, J. R., and Blake, D. R. (1988) Oxidants, inflammation, and anti-inflammatory drugs. FASEB J. 2, 2867-2873.
4. Rokutan, K., Kawahara, T., Kuwano, Y., Tominaga, K., Nishida, K., et al. (2008) Nox enzymes and oxidative stress in the immunopathology of the gastrointestinal tract. Semin. Immunopathol. 30, 315-327.
5. Griffiths, H. R. (2008) Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease? Autoimmun. Rev. 7, 544-549.
6. Mouithys-Mickalad, A. M., Zheng, S. X., Deby-Dupont, G. P., Deby, C. M., Lamy, M. M., et al. (2000) In vitro study of the antioxidant properties of non steroidal anti-inflammatory drugs by chemiluminescence and electron spin resonance (ESR). Free Radic. Res. 33, 607-621.
7. Dallegri, F., Patrone, F., Ballestrero, A., Ottonello, L., Ferrando, F., et al. (1990) Inactivation of neutrophil-derived hypochlorous acid by nimesulide-a potential mechanism for the tissue protection during Inflammation. Int. J. Tissue React. 12, 107-111.
8. Bevilacqua, M., Vago, T., Baldi, G., Renesto, E., Dallegri, F., et al. (1994) Nimesulide decreases superoxide production by inhibiting phosphodiesterase type-IV. Eur. J. Pharmacol. 268, 415-423.
9. Asanuma, M., Nishibayashi-Asanuma, S., Miyazaki, I., Kohno, M., and Ogawa, N. (2001) Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J. Neurochem. 76, 1895-1904.
10. Fernandes, E., Toste, S. A., Lima, J. L. F. C., and Reis, S. (2003) The metabolism of sulindac enhances its scavenging activity against reactive oxygen and nitrogen species. Free Radic. Biol. Med. 35, 1008-1017.
11. Fernandes, E., Costa, D., Toste, S. A., Lima, J. L. F. C., and Reis, S. (2004) In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radic. Biol. Med. 37, 1895-905.
12. Costa, D., Gomes, A., Reis, S., Lima, J. L. F. C., and Fernandes, E. (2005) Hydrogen peroxide scavenging activity by non-steroidal anti-inflammatory drugs. Life Sci. 76, 2841-2848.
13. Costa, D., Vieira, A., and Fernandes, E. (2006) Dipyrone and aminopyrine are effective scavengers of reactive nitrogen species. Redox Rep. 11, 136-142.
14. Kam, P. C. A. and See, A. U. L. (2000) Cyclo-oxygenase isoenzymes: physiological and pharmacological role. Anaesthesia 55, 442-449.
15. Cipollone, F., Cicolini, G., and Bucci, M. (2008) Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives. Pharmacol. Ther. 118, 161-180.
16. Leone, S., Ottani, A., and Bertolini, A. (2007) Dual acting anti-inflammatory drugs. Curr. Top. Med. Chem. 7, 265-275.
17. Sharma, J.N. and Mohammed, L.A. (2006) The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets? Inflammopharmacology 14, 10-16.
18. Werz, O. and Steinhilber, D. (2006) Therapeutic options for 5-lipoxygenase inhibitors. Pharmacol. Ther. 112, 701-718.
19. Khanapure, S. P., Garvey, D. S., Janero, D. R., and Letts, L. G. (2007) Eicosanoids in inflammation: Biosynthesis, pharmacology, and therapeutic frontiers. Curr. Top. Med. Chem. 7, 311-340.
20. Antman, E. M., DeMets, D., and Loscalzo, J. (2005) Cyclooxygenase inhibition and cardiovascular risk. Circulation 112, 759-770.
21. Solomon, D. H. (2005) Selective cyclooxygenase 2 inhibitors and cardiovascular events. Arthritis Rheum. 52, 1968-1978.
22. Grosser, T., Fries, S., and FitzGerald, G. A. (2006) Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J. Clin. Invest. 116, 4-15.
23. Fiorucci, S., Meli, R., Bucci, M., and Cirino, G. (2001) Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? Biochem. Pharmacol. 62, 1433-1438.
24. Hudson, N., Balsitis, M., Everitt, S., and Hawkey, C.J. (1993) Enhanced gastric-mucosal leukotriene-B(4) synthesis in patients taking nonsteroidal anti-inflammatory drugs. Gut 34, 742-747.
25. Dugas, A. J., Castaneda-Acosta, J., Bonin, G. C., Price, K. L., Fischer, N. H., and Winston, G. W. (2000) Evaluation of the total peroxyl radical-scavenging capacity of flavonoids: structure-activity relationships. J. Nat. Prod. 63, 327-331.
26. Edenharder, R. and Grunhage, D. (2003) Free radical scavenging abilities of flavonoids as mechanism of protection against mutagenicity induced by tert-butyl hydroperoxide or cumene hydroperoxide in Salmonella typhimurium TA102. Mutat. Res. 540, 1-18.
27. Hyun, J., Woo, Y., Hwang, D. S., Jo, G., Eom, S., et al. (2010) Relationships between structures of hydroxyflavones and their antioxidative effects. Bioorg. Med. Chem. Lett. 20, 5510-5513.
28. Agarwal, O. P. (1982) The anti-Inflammatory action of nepitrin, a flavonoid. Agents Actions 12, 298-302.
29. Theoharides, T. C., Alexandrakis, M., Kempuraj, D., and Lytinas, M. (2001) Anti-inflammatory actions of flavonoids and structural requirements for new design. Int. J. Immunopathol. Pharmacol. 14, 119-127.
30. Gomes, A., Fernandes, E., Silva, A. M. S., Santos, C. M. M., Pinto, D. C. G. A., et al. (2007) 2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species. Bioorg. Med. Chem. 15, 6027-6036.
31. Whiteman, M., Ketsawatsakul, U., and Halliwell, B. (2002) A reassessment of the peroxynitrite scavenging activity of uric acid. Ann. N.Y. Acad. Sci. 962, 242-259.
32. Freitas, M., Porto, G., Lima, J. L. F. C., and Fernandes, E. (2008) Isolation and activation of human neutrophils in vitro. The importance of the anticoagulant used during blood collection. Clin. Biochem. 41, 570-575.
33. Freitas, M., Lima, J. L. F. C., and Fernandes, E. (2009) Optical probes for detection and quantification of neutrophils' oxidative burst. A review. Anal. Chim. Acta 649, 8-23.
34. Bors, W., Heller, W., Michel, C., and Saran, M. (1990) Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol. 186, 343-355.
35. Gomes, A., Fernandes, E., and Lima, J. L. F. C. (2005) Fluorescence probes used for detection of reactive oxygen species. J. Biochem. Biophys. Methods 65, 45-80.
36. Setsukinai, K., Urano, Y., Kakinuma, K., Majima, H. J., and Nagano, T. (2003) Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J. Biol. Chem. 278, 3170-3175.
37. Hampton, M. B., Kettle, A. J., and Winterbourn, C. C. (1998) Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92, 3007-3017.
38. Witko-Sarsat, V., Rieu, P., Descamps-Latscha, B., Lesavre, P., and Halbwachs-Mecarelli, L. (2000) Neutrophils: molecules, functions and pathophysiological aspects. Lab. Invest. 80, 617-653.
39. Steffen, Y., Gruber, C., Schewe, T., and Sies, H. (2008) Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch. Biochem. Biophys. 469, 209-219.
40. Fisher, M. B., Paine, M. F., Strelevitz, T. J., and Wrighton, S. A. (2001) The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab. Rev. 33, 273-297.
41. Rossi, A., Ligresti, A., Longo, R., Russo, A., Borrelli, F., et al. (2002) The inhibitory effect of propolis and caffeic acid phenethyl ester on cyclooxygenase activity in J774 macrophages. Phytomedicine 9, 530-535.
42. Rossi, A., Longo, R., Russo, A., Borrelli, F., and Sautebin, L. (2002) The role of the phenethyl ester of caffeic acid (CAPE) in the inhibition of rat lung cyclooxygenase activity by propolis. Fitoterapia 73, S30-S37.
43. Raso, G. M., Meli, R., Di Carlo, G., Pacilio, M., and Di Carlo, R. (2001) Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci. 68, 921-931.
44. Noreen, Y., Ringbom, T., Perera, P., Danielson, H., and Bohlin, L. (1998) Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis. J. Nat. Prod. 61, 2-7.
45. Jampilek, J., Dolezal, M., Opletalova, V., and Hartl, J. (2006) 5-Lipoxygenase, leukotrienes biosynthesis and potential antileukotrienic agents. Curr. Med. Chem. 13, 117-129.
46. Werz, O. (2007) Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin. Planta Med. 73, 1331-1357.
47. Redrejo-Rodriguez, M., Tejeda-Cano, A., Pinto, M. D., and Macias, P. (2004) Lipoxygenase inhibition by flavonoids: semiempirical study of the structure-activity relation. J. Mol. Struct.-Theochem. 674, 121-124.
48. van Acker, S. A., de Groot, M. J., van den Berg, D. J., Tromp, M. N., Donne-Op den Kelder, G., et al. (1996) A quantum chemical explanation of the antioxidant activity of flavonoids. Chem. Res. Toxicol., 9, 1305-1312.
49. Bertolini, A., Ottani, A., and Sandrini, M. (2002) Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Curr. Med. Chem. 9, 1033-1043.
50. Burnett, B.P., Jia, Q., Zhao, Y., and Levy, R.M. (2007) A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation. J. Med. Food 10, 442-451.
51. Celotti, F. and Durand, T. (2003) The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy. Prostaglandins Other Lipid Mediat 71, 147-162.
52. Brune, K. (2004) Safety of anti-inflammatory treatment-new ways of thinking. Rheumatology (Oxford) 43, i16-i20.